Cathee Till

2.9k total citations
71 papers, 2.0k citations indexed

About

Cathee Till is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Cathee Till has authored 71 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Pulmonary and Respiratory Medicine, 25 papers in Oncology and 14 papers in Molecular Biology. Recurrent topics in Cathee Till's work include Prostate Cancer Treatment and Research (32 papers), Prostate Cancer Diagnosis and Treatment (19 papers) and Hormonal and reproductive studies (12 papers). Cathee Till is often cited by papers focused on Prostate Cancer Treatment and Research (32 papers), Prostate Cancer Diagnosis and Treatment (19 papers) and Hormonal and reproductive studies (12 papers). Cathee Till collaborates with scholars based in United States, Australia and South Africa. Cathee Till's co-authors include Ian M. Thompson, Phyllis J. Goodman, Joseph M. Unger, Dawn L. Hershman, Catherine M. Tangen, Alan R. Kristal, Lori M. Minasian, Marian L. Neuhouser, Elizabeth A. Platz and Howard L. Parnes and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and JNCI Journal of the National Cancer Institute.

In The Last Decade

Cathee Till

68 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cathee Till United States	27	670	539	421	351	254	71	2.0k
Ashraful Hoque United States	27	558 0.8×	556 1.0×	618 1.5×	767 2.2×	150 0.6×	64	2.2k
Hazem Assi Lebanon	19	408 0.6×	1.1k 2.0×	297 0.7×	552 1.6×	285 1.1×	103	2.5k
Jane C. Schroeder United States	29	232 0.3×	795 1.5×	491 1.2×	565 1.6×	191 0.8×	52	2.3k
Atsuko Shibata United States	23	362 0.5×	499 0.9×	208 0.5×	389 1.1×	116 0.5×	51	1.6k
Olufemi J. Ogunbiyi Nigeria	19	311 0.5×	456 0.8×	134 0.3×	227 0.6×	196 0.8×	70	1.8k
Kimberly A. Lowe United States	25	231 0.3×	569 1.1×	290 0.7×	276 0.8×	94 0.4×	79	2.0k
Hitoshi Ichimiya Japan	26	467 0.7×	543 1.0×	182 0.4×	352 1.0×	141 0.6×	94	1.9k
Gian Maria Busetto Italy	31	983 1.5×	434 0.8×	345 0.8×	509 1.5×	222 0.9×	153	2.6k
Antonella Zucchetto Italy	34	368 0.5×	1.2k 2.3×	549 1.3×	648 1.8×	175 0.7×	92	3.0k
Megan S. Rice United States	22	375 0.6×	411 0.8×	170 0.4×	171 0.5×	147 0.6×	92	1.8k

Countries citing papers authored by Cathee Till

Since Specialization

Citations

This map shows the geographic impact of Cathee Till's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cathee Till with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cathee Till more than expected).

Fields of papers citing papers by Cathee Till

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cathee Till. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cathee Till. The network helps show where Cathee Till may publish in the future.

Co-authorship network of co-authors of Cathee Till

This figure shows the co-authorship network connecting the top 25 collaborators of Cathee Till. A scholar is included among the top collaborators of Cathee Till based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cathee Till. Cathee Till is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hershman, Dawn L., Cathee Till, Michael LeBlanc, Scott Ramsey, & Joseph M. Unger. (2025). Development and validation of a risk prediction model for acute care use among older advanced cancer patients on clinical trials. JNCI Journal of the National Cancer Institute.

Unger, Joseph M., Cathee Till, Catherine M. Tangen, et al.. (2024). Long-Term Adverse Effects and Complications After Prostate Cancer Treatment. JAMA Oncology. 10(12). 1654–1654. 9 indexed citations

Hershman, Dawn L., Riha Vaidya, Cathee Till, et al.. (2024). Socioeconomic Deprivation and Health Care Use in Patients Enrolled in SWOG Cancer Clinical Trials. JAMA Network Open. 7(3). e244008–e244008. 5 indexed citations

Presant, Cary A., Cathee Till, Riha Vaidya, et al.. (2024). Smoking prevalence and association with sociodemographic variables in cancer clinical trial participants. Cancer. 131(1). e35560–e35560. 1 indexed citations

Unger, Joseph M., Cathee Till, Jessica Hwang, et al.. (2023). Risk prediction of hepatitis B or C or HIV among newly diagnosed cancer patients. JNCI Journal of the National Cancer Institute. 115(6). 703–711. 1 indexed citations

Schenk, Jeannette M., Cathee Till, Marian L. Neuhouser, et al.. (2022). Differential Biopsy Patterns Influence Associations between Multivitamin Use and Prostate Cancer Risk in the Selenium and Vitamin E Cancer Prevention Trial. Cancer Epidemiology Biomarkers & Prevention. 31(11). 2063–2069. 1 indexed citations

Gong, Zhihong, Anna E. Płatek, Cathee Till, et al.. (2022). Associations Between Polymorphisms in Genes Related to Oxidative Stress and DNA Repair, Interactions With Serum Antioxidants, and Prostate Cancer Risk: Results From the Prostate Cancer Prevention Trial. Frontiers in Oncology. 11. 808715–808715. 5 indexed citations

Henry, N. Lynn, Joseph M. Unger, Cathee Till, et al.. (2021). Predictors of Pain Reduction in Trials of Interventions for Aromatase Inhibitor–Associated Musculoskeletal Symptoms. JNCI Cancer Spectrum. 5(6). 2 indexed citations

Torkko, Kathleen C., Cathee Till, Catherine M. Tangen, et al.. (2020). Vitamin D Pathway and Other Related Polymorphisms and Risk of Prostate Cancer: Results from the Prostate Cancer Prevention Trial. Cancer Prevention Research. 13(6). 521–530. 4 indexed citations

10.

Hershman, Dawn L., Cathee Till, Jason D. Wright, et al.. (2020). Healthcare utilization and cost of care in elderly breast cancer patients enrolled in SWOG clinical trials. Breast Cancer Research and Treatment. 181(2). 455–463. 5 indexed citations

11.

Tangen, Catherine M., Jeannette M. Schenk, Cathee Till, et al.. (2019). Variations in prostate biopsy recommendation and acceptance confound evaluation of risk factors for prostate cancer: Examining race and BMI. Cancer Epidemiology. 63. 101619–101619. 4 indexed citations

12.

Shen, Sherry, Joseph M. Unger, Katherine D. Crew, et al.. (2018). Omega-3 fatty acid use for obese breast cancer patients with aromatase inhibitor-related arthralgia (SWOG S0927). Breast Cancer Research and Treatment. 172(3). 603–610. 33 indexed citations

13.

Albanes, Demetrius, Cathee Till, Eric A. Klein, et al.. (2014). Plasma Tocopherols and Risk of Prostate Cancer in the Selenium and Vitamin E Cancer Prevention Trial (SELECT). Cancer Prevention Research. 7(9). 886–895. 49 indexed citations

14.

Figg, William D., Cindy H. Chau, Douglas K. Price, et al.. (2014). Androgen Receptor CAG Repeat Length and TMPRSS2:ETS Prostate Cancer Risk: Results From the Prostate Cancer Prevention Trial. Urology. 84(1). 127–131. 7 indexed citations

15.

Ankerst, Donna P., et al.. (2013). Predicting Risk of Prostate Cancer in Men Receiving Finasteride: Effect of Prostate Volume, Number of Biopsy Cores, and American Urological Association Symptom Score. Urology. 82(5). 1076–1082. 5 indexed citations

16.

Yao, Song, Cathee Till, Alan R. Kristal, et al.. (2011). Serum estrogen levels and prostate cancer risk in the prostate cancer prevention trial: a nested case–control study. Cancer Causes & Control. 22(8). 1121–1131. 40 indexed citations

17.

Tang, Li, Song Yao, Cathee Till, et al.. (2011). Repeat polymorphisms in estrogen metabolism genes and prostate cancer risk: results from the Prostate Cancer Prevention Trial. Carcinogenesis. 32(10). 1500–1506. 20 indexed citations

18.

Neuhouser, Marian L., Cathee Till, Alan R. Kristal, et al.. (2010). Finasteride Modifies the Relation between Serum C-Peptide and Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial. Cancer Prevention Research. 3(3). 279–289. 28 indexed citations

19.

Platz, Elizabeth A., Cathee Till, Phyllis J. Goodman, et al.. (2009). Men with Low Serum Cholesterol Have a Lower Risk of High-Grade Prostate Cancer in the Placebo Arm of the Prostate Cancer Prevention Trial. Cancer Epidemiology Biomarkers & Prevention. 18(11). 2807–2813. 133 indexed citations

20.

Sutcliffe, Siobhan, J F Alderete, Cathee Till, et al.. (2008). Trichomonosis and subsequent risk of prostate cancer in the Prostate Cancer Prevention Trial. International Journal of Cancer. 124(9). 2082–2087. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact